Company intelligence / Profile preview

DKSH

Zurich, Zurich, Switzerlanddksh.com ↗

Ownership: Public · DKSH
Employees: ~32000
Development stage: Commercial

Overview

DKSH provides comprehensive market expansion services—including distribution/logistics, regulatory support, sales/marketing—for life science and healthcare companies across Asia Pacific and Europe. It does not have its own clinical pipeline but enables commercialization for partners’ products.

Modalities: Small moleculeBiologicMedical device
Industry: Consulting

Partnerships

Merz Pharma (aesthetic product distribution in Malaysia)Advance Pharma (distribution in East Malaysia)numerous global pharma/biotech/device manufacturers as clients/partners

Financials

Market cap: $154.3B
Total revenue: $91.4B
Enterprise value: $242B

Beyond the preview

Go deeper on DKSH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DKSH.

Explore the full profile